4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-24-018500
Chief Executive Officer sold 4,841 shares at $41.56 ($201,211)
- Chief Executive Officer acquired 126,809 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-04 | Grant or award : show line 1 in the form | +80,855 | 562,773 | D | ||
| 2024-11-04 | Grant or award : show line 2 in the form | +45,954 | 608,727 | D | ||
| 2024-11-04 | Sale : show line 3 in the form | −4,841 | $41.56 | $201,211 | 603,886 | D |
| Open-market sales · 4,841 sh · avg $41.56 · $201,211 | ||||||
Loading xslF345X05/marketforms-67278.xml…